Subscribe to our newsletter to receive the latest product updates and special offers

Upgrade to FINVIZ*Elite to get real-time quotes, intraday charts, and advanced charting tools.

Last Close
May 10 04:00PM ET
8.88
Dollar change
+4.41
Percentage change
98.66
%
IndexRUT P/E- EPS (ttm)-3.18 Insider Own4.98% Shs Outstand139.51M Perf Week80.12%
Market Cap1.25B Forward P/E- EPS next Y-0.26 Insider Trans0.00% Shs Float133.40M Perf Month106.51%
Income-398.71M PEG- EPS next Q-0.34 Inst Own58.71% Short Float33.68% Perf Quarter120.35%
Sales996.61M P/S1.25 EPS this Y95.04% Inst Trans3.21% Short Ratio6.58 Perf Half Y30.59%
Book/sh-6.18 P/B- EPS next Y4.97% ROA-27.53% Short Interest44.93M Perf Year-1.22%
Cash/sh3.50 P/C2.54 EPS next 5Y- ROE- 52W Range3.53 - 10.30 Perf YTD85.00%
Dividend Est.- P/FCF- EPS past 5Y11.55% ROI- 52W High-13.79% Beta1.42
Dividend TTM- Quick Ratio0.88 Sales past 5Y513.29% Gross Margin64.69% 52W Low151.39% ATR (14)0.71
Dividend Ex-DateDec 13, 2007 Current Ratio0.90 EPS Y/Y TTM78.36% Oper. Margin-38.53% RSI (14)86.66 Volatility10.13% 6.70%
Employees1543 Debt/Eq- Sales Y/Y TTM-26.66% Profit Margin-40.01% Recom2.00 Target Price18.00
Option/ShortYes / Yes LT Debt/Eq- EPS Q/Q69.08% Payout- Rel Volume24.88 Prev Close4.47
Sales Surprise-7.22% EPS Surprise1.32% Sales Q/Q15.94% EarningsMay 10 BMO Avg Volume6.83M Price8.88
SMA20106.92% SMA5090.50% SMA20052.33% Trades Volume169,845,772 Change98.66%
Date Action Analyst Rating Change Price Target Change
May-10-24Upgrade JP Morgan Underweight → Neutral
May-10-24Upgrade BofA Securities Underperform → Neutral $4 → $12
Aug-09-23Upgrade B. Riley Securities Neutral → Buy $15
Apr-20-23Downgrade TD Cowen Outperform → Market Perform $55 → $10
Mar-01-23Downgrade B. Riley Securities Buy → Neutral $29 → $10
Jan-09-23Reiterated B. Riley Securities Buy $74 → $37
Dec-30-22Reiterated H.C. Wainwright Buy $207 → $110
Dec-02-22Initiated Jefferies Hold
Sep-22-22Downgrade JP Morgan Neutral → Underweight $132 → $27
May-20-22Initiated BofA Securities Underperform $35
May-10-24 06:56PM
05:56PM
04:26PM
04:16PM
04:11PM
04:08PM Loading…
04:08PM
02:54PM
01:58PM
01:46PM
01:44PM
01:27PM
01:24PM
01:24PM
01:08PM
01:07PM
01:02PM Loading…
01:02PM
12:49PM
12:41PM
12:28PM
12:06PM
11:43AM
11:31AM
11:25AM
10:53AM
10:36AM
10:34AM
10:20AM
10:14AM
10:06AM
10:06AM
10:05AM Loading…
10:05AM
09:54AM
09:53AM
09:50AM
09:17AM
08:53AM
08:49AM
07:58AM
07:48AM
07:47AM
07:30AM
07:05AM
05:14AM
05:03AM
02:35AM
02:19AM
02:15AM
02:09AM
02:00AM
02:00AM
May-09-24 05:06AM
May-07-24 10:00AM
09:25AM
May-06-24 03:03PM
01:58PM
01:45PM
08:18AM
06:47AM
06:29AM
06:22AM
Apr-30-24 06:15PM
Apr-29-24 08:10AM
Apr-25-24 06:00AM
Apr-21-24 05:08AM
Apr-19-24 11:02AM
Apr-15-24 01:17PM
10:52AM
06:00AM
12:44AM
12:12AM
Apr-13-24 04:22PM
Apr-12-24 06:35AM
Apr-11-24 09:12AM
Apr-09-24 04:30PM
Apr-03-24 01:18PM
Apr-02-24 10:15AM
Apr-01-24 08:00AM
Mar-29-24 11:30AM
Mar-13-24 07:07AM
Mar-09-24 01:59AM
Mar-07-24 02:52PM
05:28AM
Mar-06-24 05:13PM
Mar-05-24 01:05PM
06:30AM
Mar-04-24 05:03AM
Mar-01-24 05:25AM
Feb-29-24 04:02PM
11:13AM
11:12AM
Feb-28-24 10:49PM
12:58PM
10:38AM
10:16AM
10:00AM
09:52AM
09:10AM
09:00AM
08:34AM
08:17AM
Novavax, Inc. Is a biotechnology company, which engages in the discovery, development, and commercialization of recombinant vaccines. The company was founded in 1987 and is headquartered in Gaithersburg, MD.
Insider Trading Relationship Date Transaction Cost #Shares Value ($) #Shares Total SEC Form 4
O'Hara ElaineEVP, Chief Strategy OfficerMar 01 '24Option Exercise5.3919,600105,64419,600Mar 05 07:30 PM
Dubovsky FilipPresident, R&DDec 14 '23Option Exercise5.692,83316,12055,150Dec 18 05:00 PM
Dubovsky FilipPresident, R&DNov 05 '23Option Exercise7.061,4009,88452,994Nov 07 05:30 PM
Dubovsky FilipPresident, R&DSep 16 '23Option Exercise7.7112,64497,48557,702Sep 19 05:16 PM
Dubovsky FilipPresident, R&DJun 16 '23Option Exercise8.044,15533,40647,065Jun 21 04:40 PM